Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significance test » significance set (Expand Search), significance testing (Expand Search), significance level (Expand Search)
test decrease » teer decrease (Expand Search), cost decreased (Expand Search), mean decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significance test » significance set (Expand Search), significance testing (Expand Search), significance level (Expand Search)
test decrease » teer decrease (Expand Search), cost decreased (Expand Search), mean decrease (Expand Search)
-
1441
-
1442
Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma...
Published 2025“…Background: Cirrhosis is associated with significant morbidity and mortality. Recent studies have highlighted the potential role of allopurinol in reducing the incidence of hepatic decompensation among individuals with cirrhosis. …”
-
1443
Routine sporotrichosis laboratory tests.
Published 2025“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”
-
1444
The test results of relative flow of emitters.
Published 2025“…The results indicate that schemes 1, 2, and 4 all have significant low-speed vortices in the return water zone (D zone). …”
-
1445
-
1446
-
1447
-
1448
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: -
1449
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: -
1450
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: -
1451
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: -
1452
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: -
1453
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: -
1454
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: -
1455
-
1456
-
1457
-
1458
-
1459
-
1460
Visualization of DNA in an untreated ISP phage stock by immunogold labelling.
Published 2024Subjects: